[VRDN] QoQ Quarter Result on 30-Jun-2018 [#Q2]

Stock
[VRDN] Viridian Therapeutics, Inc.
Announcement Date
07-Aug-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -86.96%
YoY- -19.17%
Quarter Report
VRDN's Result
VRDN's Financial Summary
View:
Show?
Quarter Result
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
Revenue 372 476 944 2,182 4,784 1,192 1,631 -62.70%
PBT -11,629 -10,317 -9,011 -8,714 -4,661 -6,386 -5,834 58.45%
Tax 339 289 362 361 167 77 113 108.14%
NP -11,629 -10,317 -9,011 -8,714 -4,661 -6,386 -5,834 58.45%
Tax Rate - - - - - - - -
Total Cost 12,001 10,793 9,955 10,896 9,445 7,578 7,465 37.27%
Ratio Analysis
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
NP Margin -3,126.08 -2,167.44 -954.56 -399.36 -97.43 -535.74 -357.69 324.85%
Per Share
31/03/19 31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 CAGR
EPS -5.65 -5.02 -4.40 -4.31 -2.64 -4.30 -4.06 24.67%
EPS Diluted -5.65 -5.02 -4.40 -4.31 -2.64 -4.30 -4.06 24.67%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.